C
JAZZ icon

Covestor’s Jazz Pharmaceuticals JAZZ Stock Holding History

Covestor’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$44K Sell
233
-427
-65% -$74.6K 0.03% 780
2025
Q4 		$112K Sell
660
-377
-36% -$57.8K 0.06% 512
2025
Q3 		$137K Buy
1,037
+33
+3% +$3.96K 0.08% 383
2025
Q2 		$107K Sell
1,004
-159
-14% -$17.3K 0.06% 518
2025
Q1 		$145K Buy
1,163
+132
+13% +$17.2K 0.1% 270
2024
Q4 		$127K Sell
1,031
-69
-6% -$8.13K 0.08% 371
2024
Q3 		$123K Sell
1,100
-106
-9% -$11.6K 0.08% 400
2024
Q2 		$129K Buy
1,206
+588
+95% +$64.6K 0.08% 356
2024
Q1 		$74K Buy
618
+320
+107% +$39.2K 0.05% 715
2023
Q4 		$37K Sell
298
-98
-25% -$12.2K 0.03% 970
2023
Q3 		$51K Buy
396
+345
+676% +$46K 0.04% 763
2023
Q2 		$6K Sell
51
-97
-66% -$13.1K ﹤0.01% 1676
2023
Q1 		$22K Sell
148
-50
-25% -$7.4K 0.02% 969
2022
Q4 		$32K Buy
198
+148
+296% +$21.7K 0.03% 892
2022
Q3 		$7K Buy
50
+49
+4,900% +$7.45K 0.01% 1398
2022
Q2 		$0 Sell
1
-1
-50% -$154 ﹤0.01% 2129
2022
Q1 		$0 Hold
2
– – ﹤0.01% 2269
2021
Q4 		$0 Buy
+2
New +$263 ﹤0.01% 2205

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Covestor's JAZZ Position: Q1 2026 in Review

Covestor reduced its Jazz Pharmaceuticals (JAZZ) stake by 65% in Q1 2026, selling an estimated $74.6K and leaving 233 shares worth $44K. The position accounts for 0.03% of the portfolio, ranked #780.

Covestor first reported a position in JAZZ in Q4 2021 and has held it in 18 quarters since. The position peaked at $145K in Q1 2025. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Covestor held 233 shares of Jazz Pharmaceuticals worth $44K as of Q1 2026.
  • Covestor sold 427 Jazz Pharmaceuticals shares in Q1 2026, an estimated $74.6K.
  • Jazz Pharmaceuticals made up 0.03% of Covestor's portfolio in Q1 2026, its #780 holding.
  • Covestor first reported a position in Jazz Pharmaceuticals in Q4 2021 and has held it in 18 quarters since.
  • Covestor's Jazz Pharmaceuticals position peaked at $145K in Q1 2025.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Covestor's 13F filing for Q1 2026, filed 5 May 2026.